Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP11B2 | P19099 | 13/20 | 0.51 |
| ▸ | CYP11B1 | P15538 | 10/20 | 0.51 |
| ▸ | PRKCZ | Q05513 | 1/20 | 0.46 |
| ▸ | CNR1 | P21554 | 1/20 | 0.44 |
| ▸ | CNR2 | P34972 | 1/20 | 0.44 |
| ▸ | IRAK4 | Q9NWZ3 | 1/20 | 0.39 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.39 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.39 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.39 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.39 |
| ▸ | CYP2B6 | P20813 | 1/20 | 0.39 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.39 |
| ▸ | MEN1 | O00255 | 1/20 | 0.39 |
| ▸ | LMNA | P02545 | 1/20 | 0.39 |
| ▸ | MAPT | P10636 | 1/20 | 0.39 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.39 |
| ▸ | CYP17A1 | P05093 | 1/20 | 0.38 |
| ▸ | SLC22A12 | Q96S37 | 1/20 | 0.37 |
| ▸ | HTR2C | P28335 | 1/20 | 0.37 |
| ▸ | KCNA5 | P22460 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1534980 | 0.83 | CYP11B2 (0.48) | CYP11B2CYP11B1MEN1LMNAMAPT | |
| SCHEMBL12428417 | 0.80 | CYP11B2 (0.51) | CYP11B2CYP11B1PRKCZCNR1CNR2 | |
| SCHEMBL12386965 | 0.80 | CYP11B2 (0.51) | CYP11B2CYP11B1PRKCZCNR1CNR2 | |
| SCHEMBL12676858 | 0.77 | CYP11B2 (0.51) | CYP11B2CYP11B1PRKCZCNR1CNR2 | |
| SCHEMBL971084 | 0.77 | PRKCZ (0.69) | CYP11B2CYP11B1PRKCZCYP3A4CYP1A2 | |
| SCHEMBL38660559 | 0.77 | PRKCZ (0.69) | CYP11B2CYP11B1PRKCZCYP3A4CYP1A2 | |
| SCHEMBL5085279 | 0.77 | CNR1 (0.53) | CYP11B2CYP11B1PRKCZCNR1CNR2 | |
| SCHEMBL24871209 | 0.76 | PRKCZ (0.67) | CYP11B2CYP11B1PRKCZCYP3A4CYP1A2 | |
| SCHEMBL20873080 | 0.76 | NPC1 (0.54) | CYP11B2CYP11B1PRKCZCNR1CNR2 | |
| SCHEMBL1445121 | 0.76 | CYP11B2 (0.50) | CYP11B2CYP11B1PRKCZCNR1CNR2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 16 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2024109660-A1 | CDK INHIBITORS | 上海齐鲁制药研究中心有限公司 | 2024-05-30 | — | — | WO | disclosed |
| US-8735577-B2 | 1,3,5-triazine derivative, process for producing same, and organic electroluminescent element comprising same as constituent component | TOSOH CORPORATION (JP) | 2014-05-27 | — | — | US | disclosed |
| US-8735577-B2 | 1,3,5-triazine derivative, process for producing same, and organic electroluminescent element comprising same as constituent component | TOSOH CORPORATION (JP) | 2014-05-27 | — | — | US | disclosed |
| US-8735577-B2 | 1,3,5-triazine derivative, process for producing same, and organic electroluminescent element comprising same as constituent component | TOSOH CORPORATION (JP) | 2014-05-27 | — | — | US | disclosed |
| EP-2351750-B1 | 1,3,5-TRIAZINE DERIVATIVE, PROCESS FOR PRODUCING SAME, AND ORGANIC ELECTROLUMINESCENT DEVICE COMPRISING SAME AS CONSTITUENT | TOSOH CORP (JP) | 2014-03-12 | — | — | EP | disclosed |
| US-8367219-B2 | Anthracene-based compound and organic light emitting device employing the same | SAMSUNG ELECTRONICS CO., LTD. (KR) | 2013-02-05 | — | — | US | disclosed |
| US-8367220-B2 | Anthracene-based compound and organic light emitting device employing the same | SAMSUNG ELECTRONICS CO., LTD. (KR) | 2013-02-05 | — | — | US | disclosed |
| CN-102239161-A | 1,3, 5-triazine derivative, method for producing same, and organic electroluminescent device comprising same as constituent | TOSOH CORP | 2011-11-09 | — | — | CN | disclosed |
| US-20110190494-A1 | 1,3,5-TRIAZINE DERIVATIVE, PROCESS FOR PRODUCING SAME, AND ORGANIC ELECTROLUMINESCENT ELEMENT COMPRISING SAME AS CONSTITUENT COMPONENT | TOSOH CORPORATION (JP) | 2011-08-04 | — | — | US | disclosed |
| US-20110190494-A1 | 1,3,5-TRIAZINE DERIVATIVE, PROCESS FOR PRODUCING SAME, AND ORGANIC ELECTROLUMINESCENT ELEMENT COMPRISING SAME AS CONSTITUENT COMPONENT | TOSOH CORPORATION (JP) | 2011-08-04 | — | — | US | disclosed |
| US-20110190494-A1 | 1,3,5-TRIAZINE DERIVATIVE, PROCESS FOR PRODUCING SAME, AND ORGANIC ELECTROLUMINESCENT ELEMENT COMPRISING SAME AS CONSTITUENT COMPONENT | TOSOH CORPORATION (JP) | 2011-08-04 | — | — | US | disclosed |
| EP-2351750-A1 | 1,3,5-TRIAZINE DERIVATIVE, PROCESS FOR PRODUCING SAME, AND ORGANIC ELECTROLUMINESCENT ELEMENT COMPRISING SAME AS CONSTITUENT COMPONENT | Tosoh Corporation (JP) | 2011-08-03 | — | — | EP | disclosed |
| CN-101570536-A | Anthracene-based compound and organic light emitting device employing the same | SAMSUNG ELECTRONICS CO LTD (KR) | 2009-11-04 | — | — | CN | disclosed |
| US-20090166670-A1 | Anthracene-based compound and organic light emitting device employing the same | SAMSUNG DISPLAY CO., LTD. (KR) | 2009-07-02 | — | — | US | disclosed |
| EP-2055702-A1 | Anthracene-based compound and organic light emitting device employing the same | Samsung Electronics Co., Ltd. (KR) | 2009-05-06 | — | — | EP | disclosed |
| US-20090108746-A1 | Anthracene-based compound and organic light emitting device employing the same | SAMSUNG DISPLAY CO., LTD. (KR) | 2009-04-30 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110190494-A1 | 1,3,5-TRIAZINE DERIVATIVE, PROCESS FOR PRODUCING SAME, AND ORGANIC ELECTROLUMINESCENT ELEMENT COMPRISING SAME AS CONSTITUENT COMPONENT | ASH2L, SETDB1, KAT5 | CYP11B2 1254/4885CYP11B1 1323/4885PRKCZ 4761/4885 |
| US-20090166670-A1 | Anthracene-based compound and organic light emitting device employing the same | CCNL2, CRY2, ATXN2L | CYP11B2 1213/4885CYP11B1 1455/4885PRKCZ 4592/4885 |
| US-20090108746-A1 | Anthracene-based compound and organic light emitting device employing the same | CCNL2, CRY2, ATXN2L | CYP11B2 1213/4885CYP11B1 1455/4885PRKCZ 4592/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.